Evidence map›Paper›PMID 33918393›Full record

ArticleGenes2021

Sylvie Gerber, Christophe Orssaud, Josseline Kaplan, Catrine Johansson, Jean-Michel Rozet

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. RecessiveJournal of medical genetics · 2023
    Article
  11. International journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Case report: Mutations inFrontiers in neurology · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sylvie GerberLaboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris Descartes University, 75015 Paris, France.
Christophe OrssaudUnité Ophtalmologie, Hôpital Européen Georges-Pompidou (HEGP), and Centre de Référence des Maladies Rares en Ophtalmologie (OPHTARA), Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, 75015 Paris, France.ORCID 0000-0003-2585-2114
Josseline KaplanLaboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris Descartes University, 75015 Paris, France.
Catrine JohanssonBotnar Research Centre, Nuffield Orthopaedic Centre, Headington, University of Oxford, Oxford OX3 7LD, UK.ORCID 0000-0002-7431-3208
Jean-Michel RozetLaboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris Descartes University, 75015 Paris, France.ORCID 0000-0001-7951-7886
Inserm · FRHôpital Necker-Enfants Malades · FRNuffield Orthopaedic Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological variants in the nuclear malonyl-CoA-acyl carrier protein transacylase (

Indexed as

MutationAcyl-Carrier Protein S-MalonyltransferaseFemaleFranceHumansModels, MolecularOptic Atrophy, Hereditary, LeberPedigreeProtein ConformationSequence Analysis, DNAYoung AdultAcyl-Carrier Protein S-Malonyltransferasehereditary optic neuropathy (HON)MCATnuclear LHON-like

Identifiers

PMID33918393
PMCPMC8067165
OpenAlexW3152328266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.